Latest Loan Facility News

MCS Services Limited reported a $644k cash outflow from operations in Q1 2025 while lodging multiple traffic management tenders and exploring growth strategies. The company continues to consider selling its Traffic Business subsidiary, Highways Traffic Pty Ltd.

Zelira Therapeutics has made significant progress in its HOPE 1 clinical trial program, completing a key FDA submission and securing a $650,000 non-dilutive R&D loan facility to support ongoing development and working capital needs.

Reward Minerals has acquired a key exploration licence covering the Beyondie Potash Plant and is progressing its proprietary potash processing technologies alongside new copper and gold exploration initiatives.

Clean TeQ Water Limited reports strong Q1 FY26 progress, securing major contracts and boosting cash reserves amid advancing proprietary water treatment technologies.

Minbos Resources advances its Cabinda phosphate fertilizer project with key funding restructures, minority shareholder buyouts, and the start of early mining operations. Strategic partnerships and construction milestones position the company for growth despite funding delays.

Pantoro Gold reported a solid Q1 FY2026 with 19,551 ounces produced despite operational hiccups, reaffirming full-year guidance and unveiling promising high-grade exploration results at Norseman.

International Equities Corporation Ltd reported a modest revenue increase for Q1 2025-26 but faced a sharper after-tax loss, pressured by weak tourism and rising costs. Despite challenges, the company maintains a strong liquidity buffer.

Audalia Resources completed key drilling and metallurgical programs at its Medcalf vanadium-titanium-iron project, progressing towards a resource upgrade and mine design. However, cash reserves and funding runway remain limited, underscoring the need for successful financing.

Orion Minerals reported a net cash outflow of A$3.1 million for the September 2025 quarter but has secured an $8.6 million capital raise post-quarter to support ongoing project development and operations.

Fintech firm 8common has kicked off FY26 with an 8% rise in SaaS and transaction revenue, positive operational cashflow, and a renewed multi-year government contract.

Lumos Diagnostics reported steady quarterly revenue with a 300% surge in product sales, driven by its flagship FebriDx® test. The company inked a landmark US$317 million exclusive U.S. distribution agreement and awaits FDA feedback on its CLIA waiver application.

Fortescue Metals Group kicked off FY26 with record iron ore shipments and strengthened its decarbonisation strategy through new partnerships and a $2 billion Renminbi loan.